Trophogen Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 4

Trophogen General Information

Description

Operator of a biotechnology company designed to focus on the development of growth factors for therapeutic applications. The company's biotechnology services offer high-affinity glycoprotein hormone and related growth factor analogs, enabling patients to treat ovarian, breast, prostate, testicular and thyroid cancers as well as human and animal infertility.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Primary Office
  • 9714 Medical Center Drive
  • Suite 1114
  • Rockville, MD 20850
  • United States
+1 (301) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Trophogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Secondary Transaction - Private 00.00 Completed Generating Revenue
13. Later Stage VC (Series B) 14-Feb-2017 0000 Cancelled Generating Revenue
12. Grant 08-Jul-2015 00000 00.00 Completed Generating Revenue
11. Grant 21-Apr-2014 00.000 00.00 Completed Generating Revenue
10. Grant 01-Nov-2013 00.000 00.00 Completed Generating Revenue
9. Grant 11-Sep-2012 00000 00.00 Completed Generating Revenue
8. Grant 12-Sep-2011 00.000 00.00 Completed Generating Revenue
7. Grant 29-Oct-2010 00000 00.00 Completed Generating Revenue
6. Grant 23-Jul-2010 $1.74M $3.5M Completed Generating Revenue
5. Grant 01-Sep-2008 $1.77M $3.5M Completed Generating Revenue
To view Trophogen’s complete valuation and funding history, request access »

Trophogen Executive Team (4)

Name Title Board Seat Contact Info
Bruce Weintraub MD Co-Founder, President & Chief Executive Officer
Mariusz Szkudlinski MD Co-Founder, Chief Scientific Officer & Executive Vice President
You’re viewing 2 of 4 executive team members. Get the full list »

Trophogen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trophogen Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Toucan Capital Venture Capital Minority 000 0000 000000 0
To view Trophogen’s complete investors history, request access »